SCI Cancer Clinical Trials Office Blog

News & Updates from the SCI-CCTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • Cancer Clinical Trials Office
  • Stanford Cancer Institute

CCTO Office Hours

July 22, 2020 - SCI Communications

Quality Assurance Virtual Chat

This Zoom Virtual Chat is available to all CCTO staff where you can ask any quality related questions. Each discussion will be kept private. To join the meeting, please click on the link below and wait for a team member to let you into the virtual chat. There may be a short wait if there are other callers ahead of you, but we open the door as soon as we can. Even if you don’t have a question, feel free to call or logon to meet some of the Quality Assurance monitors.

Join our Quality Assurance Team in the Zoom Virtual Chat every Wednesday from 10-10:30am.

Zoom Link: https://stanford.zoom.us/j/95111693670
Passcode: 488792

If you are unable to attend the QA Virtual Chat, please send us your questions to dsmc-quality@stanford.edu

Reminder: HR Ticket System and Office Hours

Do you have HR questions?

Our SCI/CCTO HR Team is here to help! Submit a case ticket to your HR Team via AskMySCI-HR. 
Please use this link to submit requests, issues, and inquiries.

Join Your HR Team During our ZOOM Virtual Hour Mon, Wed, Fri from 2pm-3pm: 
https://stanford.zoom.us/j/895250203
Password: 800802

Blog Submissions

If you have an announcement for the blog, please complete the Comms Request Form.

Reminder: Please have your blog post submitted to us by noon on Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • kudos
  • OnCore
  • Quality Corner
  • Regulatory Updates
  • Remote Monitoring
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube